EP300 and Cerebral ischemia: Therapeutically, targeting p300 with specific inhibitors offers a promising strategy to modulate aberrant lactylation, protect neuronal integrity, and suppress maladaptive glial responses in the aftermath of cerebral ischemia (Lan et al., 2025).